18 Biggest Mid-Day Losers For Thursday

Loading...
Loading...
  • Stemline Therapeutics Inc STML shares tumbled 32.8 percent to $6.55. A cancer patient died from side effect in Stemline Therapeutics’ SL-401 drug trial, according to TheStreet.com's Adam Feuerstein.
  • CSG Systems International, Inc. CSGS fell 17.6 percent to $39.76. CSG Systems reported a Q4 profit of $12.6 million on revenue of $195.2 million.
  • Seadrill Ltd SDRL dropped 17.6 percent to $1.62. Seadrill shares have gained 4.26 percent over the past 52 weeks, while the S&P 500 index has climbed 19.79 percent in the same period.
  • Resolute Forest Products Inc RFP shares dipped 15.6 percent to $4.60. Resolute reported a Q4 net loss of $45 million, or $0.50 per share, versus a year-ago net loss of $214 million , or $2.39 per share.
  • Shutterfly, Inc. SFLY shares declined 15.1 percent to $43.95 after the company reported weaker-than-expected Q4 results.
  • Corium International Inc CORI shares declined 14.5 percent to $3.15. Corium priced its follow-on offering of 6.66 million shares of common stock at $3 per share.
  • Aviragen Therapeutics Inc AVIR shares dropped 13.8 percent to $1.06 after the company reported top-line results from Phase 2a RSV challenge study of BTA585. The data depicted that there was not a significant reduction in primary endpoint.
  • Cirrus Logic, Inc. CRUS dropped 13.7 percent to $55.22. Cirrus Logic posted upbeat results for its third quarter.
  • Civeo Corporation (Canada) CVEO shares fell 12 percent to $3.17. Civeo reported an offering of 20 million shares of common stock.
  • Ralph Lauren Corp RL shares tumbled 11.7 percent to $77.13 after the company reported the departure of its CEO. Ralph Lauren reported Q3 adjusted earnings of $1.86 per share on revenue of $1.7 billion.
  • Edwards Lifesciences Corp EW dropped 9.4 percent to $88.79. Edwards Lifesciences reported Q4 adjusted earnings of $0.75 per share on revenue of $768 million. BTIG Research downgraded Edwards Lifesciences from Buy to Neutral.
  • Autoliv Inc. ALV shares fell 8.6 percent to $106.42 following weak Q4 results.
  • Mellanox Technologies, Ltd. MLNX declined 8.6 percent to $42.80 after reporting downbeat Q4 results.
  • First Bancorp FBP declined 7.8 percent to $6.32. First BanCorp disclosed that THL and Oaktree have commence secondary offering of shares.
  • Novo Nordisk A/S (ADR) NVO dropped 7.7 percent to $33.85 after reporting weak Q4 profit.
  • CymaBay Therapeutics Inc CBAY shares fell 6.3 percent to $1.95. CymaBay reported a proposed public offering of common stock.
  • CVS Health Corp CVS declined 4.6 percent to $74.39. Baird downgraded CVS Health from Outperform to Neutral.
  • Metlife Inc MET shares fell 3 percent to $52.25 after the company posted weaker-than-expected results for its fourth quarter.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...